Mauricio Tohen

Active 1984–2025

146
Papers
25,071
Citations
95
h-index
140
i10-index

Citations

Citations per year for Mauricio Tohen1974: 1 citations1978: 1 citations1987: 3 citations1988: 1 citations1989: 3 citations1990: 6 citations1992: 10 citations1993: 14 citations1994: 11 citations1995: 24 citations1996: 24 citations1997: 26 citations1998: 62 citations1999: 101 citations2000: 145 citations2001: 159 citations2002: 156 citations2003: 237 citations2004: 193 citations2005: 341 citations2006: 265 citations2007: 314 citations2008: 265 citations2009: 304 citations2010: 258 citations2011: 238 citations2012: 207 citations2013: 190 citations2014: 183 citations2015: 164 citations2016: 165 citations2017: 152 citations2018: 146 citations2019: 392 citations2020: 373 citations2021: 326 citations2022: 257 citations2023: 216 citations2024: 331 citations2025: 139 citations2026: 4 citations1975–1977: no citations, so these years are not shown1979–1986: no citations, so these years are not shown1991: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,190 citing papers, 30% of this breakdownUnited Kingdom: 652 citing papers, 8.9% of this breakdownCanada: 515 citing papers, 7.1% of this breakdownSpain: 405 citing papers, 5.5% of this breakdownItaly: 383 citing papers, 5.2% of this breakdownGermany: 362 citing papers, 5% of this breakdownAustralia: 360 citing papers, 4.9% of this breakdownChina: 220 citing papers, 3% of this breakdownBrazil: 180 citing papers, 2.5% of this breakdownNetherlands: 178 citing papers, 2.4% of this breakdownJapan: 160 citing papers, 2.2% of this breakdownFrance: 152 citing papers, 2.1% of this breakdown
0%30%Other 21.2%

Fields

  • Medicine76.5%
  • Neuroscience11.4%
  • Psychology6.6%
  • Biochemistry, Genetics and Molecular Biology2.6%
  • Arts and Humanities0.5%
  • Health Professions0.4%
  • Other2%

Topics

  • Schizophrenia research and treatment17.1%
  • Bipolar Disorder and Treatment16.4%
  • Treatment of Major Depression6.8%
  • Tryptophan and brain disorders5.5%
  • Electroconvulsive Therapy Studies3.9%
  • Mental Health and Psychiatry3.2%
  • Other47.1%

Coauthors

All papers

Open in search
  1. Neuroimaging Biomarkers in Schizophrenia

    Authors: , , , , , - American Journal of Psychiatry 2021 cited by 248

  2. Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression

    Authors: , , , , , - American Journal of Psychiatry 2015 cited by 591

  3. The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Frederick Cassidy, Hagop S. Akiskal, Jean-Michel Azorin, Marc Valentí, Diego Hidalgo‐Mazzei, Beny Lafer, Tadafumi Kato, Lorenzo Mazzarini, Anabel Martínez‐Arán, Gordon Parker, Daniel Souery, Ayşegül Özerdem, Susan L. McElroy, Paolo Girardi, Michael Bauer, Lakshmi N. Yatham, Carlos A. Zarate, Andrew A. Nierenberg, Boris Birmaher, Shigenobu Kanba, Rif S. El‐Mallakh, Alessandro Serretti, Zoltán Rihmer, Allan H. Young, Georgios D. Kotzalidis, Glenda MacQueen, Charles L. Bowden, S. Nassir Ghaemi, Carlos López‐Jaramillo, Janusz Rybakowski, Kyooseob Ha, Giulio Perugi, Siegfried Kasper, Jay D. Amsterdam, Robert M. A. Hirschfeld, Flávio Kapczinski, Eduard Vieta - American Journal of Psychiatry 2013 cited by 754

  4. Lithium treatment of Bipolar disorder in adults: A systematic review of randomized trials and meta-analyses

    Authors: , , - European Neuropsychopharmacology 2021 cited by 134

  5. The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders

    Authors: , , , , , , , , , , , , , , , , , , - Bipolar Disorders 2009 cited by 507

  6. Early Intervention in Bipolar Disorder

    Authors: , , , , , , , , - American Journal of Psychiatry 2018 cited by 351

  7. Randomized, Double-Blind Trial of Olanzapine Versus Placebo in Patients Prodromally Symptomatic for Psychosis

    Authors: , , , , , , , , , , , , , , - American Journal of Psychiatry 2006 cited by 557

  8. Social media recruitment for mental health research: A systematic review

    Authors: , , , , , , , , , , , , , , - Comprehensive Psychiatry 2020 cited by 109

  9. The Economic Burden of Bipolar Disorder in the United States: A Systematic Literature Review

    Authors: , , , , - ClinicoEconomics and Outcomes Research 2020 cited by 138

  10. Efficacy and safety of cariprazine in bipolar I depression: A double‐blind, placebo‐controlled phase 3 study

    Authors: , , , , , , - Bipolar Disorders 2019 cited by 245

  11. Preventing new episodes of bipolar disorder in adults: Systematic review and meta-analysis of randomized controlled trials

    Authors: , , , , , - European Neuropsychopharmacology 2021 cited by 88

  12. Olanzapine Versus Lithium in the Maintenance Treatment of Bipolar Disorder: A 12-Month, Randomized, Double-Blind, Controlled Clinical Trial

    Authors: , , , , , , , , , , , , , , , , - American Journal of Psychiatry 2005 cited by 366

  13. Young Mania Rating Scale: how to interpret the numbers? Determination of a severity threshold and of the minimal clinically significant difference in the EMBLEM cohort

    Authors: , , , , , , , , , - International Journal of Methods in Psychiatric Research 2013 cited by 124

  14. Efficacy of Olanzapine and Olanzapine-Fluoxetine Combination in the Treatment of Bipolar I Depression

    Authors: , , , , , , , , , , , , , , - Archives of General Psychiatry 2003 cited by 910

  15. What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD/IGSLI Task Force on treatment with lithium

    Authors: , , , , , , , , , , , - Bipolar Disorders 2019 cited by 156

  16. The CINP Guidelines on the Definition and Evidence-Based Interventions for Treatment-Resistant Bipolar Disorder

    Authors: , , , , , , , , - The International Journal of Neuropsychopharmacology 2019 cited by 77

  17. Adjunctive lumateperone (ITI‐007) in the treatment of bipolar depression: Results from a randomized placebo‐controlled clinical trial

    Authors: , , , , , , , , , , - Bipolar Disorders 2023 cited by 27

  18. A systematic review of interventions in the early course of bipolar disorder I or II: a report of the International Society for Bipolar Disorders Taskforce on early intervention

    Authors: , , , , , , , , , , , , , , , , , , - International Journal of Bipolar Disorders 2023 cited by 40

  19. Efficacy of Olanzapine in Acute Bipolar ManiaA Double-blind, Placebo-Controlled Study

    Authors: - Archives of General Psychiatry 2000 cited by 544

  20. An International Society of Bipolar Disorders task force report: Precursors and prodromes of bipolar disorder

    Authors: , , , , , , , , , , , , , , , , , , , , , - Bipolar Disorders 2019 cited by 118

  21. Complex polypharmacy in bipolar disorder: Side effect burden, adherence, and response predictors

    Authors: , , , , , , , , , , , , , - Journal of Affective Disorders 2019 cited by 44

  22. One hundred years of schizophrenia: a meta-analysis of the outcome literature

    Authors: , , , , - American Journal of Psychiatry 1994 cited by 764

  23. Olanzapine Versus Divalproex Sodium for the Treatment of Acute Mania and Maintenance of Remission: A 47-Week Study

    Authors: , , , , , , , , , , - American Journal of Psychiatry 2003 cited by 347

  24. Randomized, Placebo-Controlled Trial of Olanzapine as Maintenance Therapy in Patients With Bipolar I Disorder Responding to Acute Treatment With Olanzapine

    Authors: , , , , , , , , - American Journal of Psychiatry 2006 cited by 316